Sri Lanka’s Institute of Allergology and Immunology: Pioneering a Novel Era in Allergy and Immunity Care
What began as a small operation in a house in Gangodawila, Nugegoda, and later shared space with the Family Practice Centre, has blossomed into a state-of-the-art Institute of Allergology and Immunology (IAI). This new four-story facility, located within the Faculty of Medical Sciences of the University of Sri Jayewardenepura, represents a significant leap forward in Sri Lanka’s capacity for research, education, and clinical care in the critical fields of allergology and immunology.
From Humble Beginnings to a National Hub
The IAI’s journey reflects a growing recognition of the importance of understanding and addressing allergic diseases and immune system disorders. Around 2008, research in this area was limited. The establishment of the Centre for Dengue Research (CDR) in 2012, spearheaded by Prof. Neelika Malavige, marked a turning point. This initial success led to the creation of the Centre for Primary Care and Allergy Research, directed by Prof. Chandima Jeewandara.
Recognizing the synergy between these efforts, a merger created an independent unit to enhance research efficiency and foster international collaborations. However, challenges remained. Prior to the IAI’s construction, the team faced bureaucratic hurdles, limited space, and a lack of dedicated laboratories, hindering their ability to conduct timely and comprehensive research.
Overcoming Obstacles and Securing Sustainability
Securing approvals for essential resources, such as importing materials and signing agreements with international institutions, proved difficult. Researchers often faced restrictions on working hours, as laboratory tests couldn’t be paused based on a standard workday. The need for dedicated funding and a sustainable financial model was paramount.
The IAI’s funding model prioritizes sustainability, with 25% coming from the government and the remainder secured through competitive research grants. This approach, championed by Prof. Jeewandara, ensures financial independence and minimizes the burden on the national treasury. The institute has already secured funding through collaborations with institutions like Sungkyunkwan University in South Korea.
Cutting-Edge Facilities and International Partnerships
The newly constructed IAI boasts state-of-the-art equipment, including the Phadia 250, the only such device in Sri Lanka, used for detecting allergen-specific IgE to pinpoint specific allergies. The institute’s platinum-grade green building rating underscores its commitment to environmental sustainability.
The IAI has forged strong partnerships with leading international institutions, including Oxford University, Imperial College London, Duke-NUS Singapore, the University of North Carolina, and the World Health Organisation (WHO). These collaborations will facilitate knowledge exchange, research advancements, and the adoption of best practices.
Focus Areas: Research, Education, and Clinical Care
The IAI’s core mission revolves around three key pillars: research, education, and clinical care. Research efforts will focus on areas such as dengue diagnostics, infectious diseases (including COVID-19, influenza, and tuberculosis), microbiome studies, autoimmunity, and biomedical engineering. The institute is also exploring the potential of traditional medicine and medicinal plants for treating infectious diseases and allergies, with several patents already filed.
Education will encompass a wide range of programs, from Bachelor of Science (B.Sc) to doctoral (PhD) level, as well as specialized medical degrees (MD). Clinically, the IAI will serve as a national referral centre for allergic diseases, offering weekly clinics, epi-pen distribution, and advanced laboratory testing.
As of 2024, the IAI had registered over 2,000 patients and distributed more than 1,000 epi-pens, demonstrating its immediate impact on patient care.
Looking Ahead: A Vision for the Future
The IAI’s ultimate goal is to improve the quality of life for Sri Lankans by detecting epidemics early, developing cost-effective interventions and diagnostics, and leveraging indigenous knowledge to create solutions tailored to the country’s specific needs. Prof. Jeewandara emphasizes the importance of developing “solutions suitable for our country and our people and not ‘imported solutions’.”
Frequently Asked Questions
- What is the main purpose of the IAI? The IAI is dedicated to research, education, and clinical care in allergology and immunology.
- Where is the IAI located? The IAI is located within the Faculty of Medical Sciences of the University of Sri Jayewardenepura in Nugegoda.
- What types of allergies does the IAI treat? The IAI provides care for a wide range of allergic diseases.
- How is the IAI funded? The IAI is funded through a combination of government contributions and competitive research grants.
Pro Tip: Early diagnosis and management of allergies can significantly improve quality of life. If you suspect you have an allergy, consult with a healthcare professional.
Learn more about allergy testing and treatment options at the Family Practice Centre at the University of Sri Jayewardenepura.
Do you have questions about allergies or immunology? Share your thoughts in the comments below!
